BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cianna Medical Announces Issued Patents for SAVI Multi-Catheter Brachytherapy Device


3/24/2009 7:16:28 AM

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Cianna Medical announced today that the U.S. Patent and Trademark Office issued two patents that are directly related to its SAVI™ multi-catheter brachytherapy device for the treatment of breast cancer. The patents, Nos. 7,497,819 and 7,497,820 and titled “Expandable Brachytherapy Device,” represent the first patents issued for a family of applications focused in brachytherapy.

The SAVI multi-catheter open architecture design allows for the delivery of patient-specific radiation that minimizes the radiation dose to healthy tissue. Published reports and clinical experience show that most women who are excluded from balloon brachytherapy because of the location of the lesion or breast size can receive treatment with the SAVI delivery system.

“These two patents are the first of many we expect to secure through our comprehensive intellectual property portfolio,” said Jill Anderson, President and CEO of Cianna Medical. “We are well positioned to protect our products and our leadership in the breast brachytherapy market. Strong IP and innovative, proven technology make Accelerated Partial Beast Irradiation (APBI) with SAVI a viable therapy for women suffering from breast cancer.”

Cianna received 510(k) clearance for SAVI from the U.S. Food and Drug Administration in August 2007 for use during brachytherapy procedures. For appropriate patients, SAVI is an advanced technology that may reduce treatment time to just five days, versus six to eight weeks for traditional radiation therapy.

About Cianna Medical, Inc.

Cianna Medical, Inc. is a medical device company focused on women's health and dedicated to the innovative treatment of early-stage breast cancer. The company manufactures and markets the SAVI breast brachytherapy applicator, for the delivery of radiation after lumpectomy surgery. The SAVI applicator allows contouring of the radiation dose, and is designed to make the benefits of accelerated partial breast irradiation available to a greater number of women. For more information about the company, call (toll-free) 866-920-9444 or visit www.CiannaMedical.com.

Contact:

Dowling & Dennis Public Relations Liz Dowling, 760-942-2544 Liz@DowlingDennis.net

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES